Influenza A virus and TLR7 activation potentiate NOX2 oxidase-dependent ROS production in macrophages
Abstract Influenza A virus infects resident alveolar macrophages in the respiratory tract resulting in Toll like receptor 7 (TLR7) activation that triggers an inflammatory response to resolve the infection. Macrophages are also major sources of reactive oxygen species (ROS) via the NOX2-containing N...
Saved in:
Published in | Free radical research Vol. 48; no. 8; pp. 940 - 947 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Informa Healthcare
01.08.2014
Taylor & Francis |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Influenza A virus infects resident alveolar macrophages in the respiratory tract resulting in Toll like receptor 7 (TLR7) activation that triggers an inflammatory response to resolve the infection. Macrophages are also major sources of reactive oxygen species (ROS) via the NOX2-containing NADPH oxidase. Although ROS are crucial for pathogen clearance, in response to influenza A virus, ROS are touted as being culprit mediators of the lung tissue injury. The aim of the present study was to determine whether influenza A virus infection and TLR7 activation of macrophages, results in alterations in their ROS production. Here we demonstrate using immunofluorescence that influenza A virus (Hong Kong X-31 strain; H3N2) internalizes in RAW264.7 cells and mouse alveolar macrophages within 1 h, resulting in a significant enhancement in the stimulated NOX2 oxidase-dependent oxidative burst, although virus had no effect on basal ROS. The specific TLR7 agonist imiquimod (10 μg/ml) elevated basal superoxide production and, in a similar fashion to influenza A virus, enhanced NOX2 oxidase-dependent oxidative burst. By contrast, the TLR3 agonist, poly I:C (1-100 μg/ml) failed to influence the oxidative burst to NOX2 oxidase. A peptide corresponding to the region 337-348 on p47phox conjugated to a HIV-tat, designed to inhibit the phosphorylation of Ser346 on p47phox suppressed the influenza A virus- and imiquimod-induced enhancement in the oxidative burst. In conclusion, this study demonstrates for the first time that influenza A virus and TLR7 activation enhance the NOX2 oxidase-dependent oxidative burst in macrophages, which might underpin the acute lung injury to influenza A virus infection. |
---|---|
AbstractList | Influenza A virus infects resident alveolar macrophages in the respiratory tract resulting in Toll like receptor 7 (TLR7) activation that triggers an inflammatory response to resolve the infection. Macrophages are also major sources of reactive oxygen species (ROS) via the NOX2-containing NADPH oxidase. Although ROS are crucial for pathogen clearance, in response to influenza A virus, ROS are touted as being culprit mediators of the lung tissue injury. The aim of the present study was to determine whether influenza A virus infection and TLR7 activation of macrophages, results in alterations in their ROS production. Here we demonstrate using immunofluorescence that influenza A virus (Hong Kong X-31 strain; H3N2) internalizes in RAW264.7 cells and mouse alveolar macrophages within 1 h, resulting in a significant enhancement in the stimulated NOX2 oxidase-dependent oxidative burst, although virus had no effect on basal ROS. The specific TLR7 agonist imiquimod (10 μg/ml) elevated basal superoxide production and, in a similar fashion to influenza A virus, enhanced NOX2 oxidase-dependent oxidative burst. By contrast, the TLR3 agonist, poly I:C (1-100 μg/ml) failed to influence the oxidative burst to NOX2 oxidase. A peptide corresponding to the region 337-348 on p47phox conjugated to a HIV-tat, designed to inhibit the phosphorylation of Ser346 on p47phox suppressed the influenza A virus- and imiquimod-induced enhancement in the oxidative burst. In conclusion, this study demonstrates for the first time that influenza A virus and TLR7 activation enhance the NOX2 oxidase-dependent oxidative burst in macrophages, which might underpin the acute lung injury to influenza A virus infection. Abstract Influenza A virus infects resident alveolar macrophages in the respiratory tract resulting in Toll like receptor 7 (TLR7) activation that triggers an inflammatory response to resolve the infection. Macrophages are also major sources of reactive oxygen species (ROS) via the NOX2-containing NADPH oxidase. Although ROS are crucial for pathogen clearance, in response to influenza A virus, ROS are touted as being culprit mediators of the lung tissue injury. The aim of the present study was to determine whether influenza A virus infection and TLR7 activation of macrophages, results in alterations in their ROS production. Here we demonstrate using immunofluorescence that influenza A virus (Hong Kong X-31 strain; H3N2) internalizes in RAW264.7 cells and mouse alveolar macrophages within 1 h, resulting in a significant enhancement in the stimulated NOX2 oxidase-dependent oxidative burst, although virus had no effect on basal ROS. The specific TLR7 agonist imiquimod (10 μg/ml) elevated basal superoxide production and, in a similar fashion to influenza A virus, enhanced NOX2 oxidase-dependent oxidative burst. By contrast, the TLR3 agonist, poly I:C (1-100 μg/ml) failed to influence the oxidative burst to NOX2 oxidase. A peptide corresponding to the region 337-348 on p47phox conjugated to a HIV-tat, designed to inhibit the phosphorylation of Ser346 on p47phox suppressed the influenza A virus- and imiquimod-induced enhancement in the oxidative burst. In conclusion, this study demonstrates for the first time that influenza A virus and TLR7 activation enhance the NOX2 oxidase-dependent oxidative burst in macrophages, which might underpin the acute lung injury to influenza A virus infection. |
Author | To, E. E. Broughton, B. R. S. Hendricks, K. S. Selemidis, S. Vlahos, R. |
Author_xml | – sequence: 1 givenname: E. E. surname: To fullname: To, E. E. email: Stavros.selemidis@monash.edu, Stavros.selemidis@monash.edu organization: Department of Pharmacology, Monash University – sequence: 2 givenname: B. R. S. surname: Broughton fullname: Broughton, B. R. S. email: Stavros.selemidis@monash.edu, Stavros.selemidis@monash.edu organization: Department of Pharmacology, Monash University – sequence: 3 givenname: K. S. surname: Hendricks fullname: Hendricks, K. S. email: Stavros.selemidis@monash.edu, Stavros.selemidis@monash.edu organization: Department of Pharmacology, Monash University – sequence: 4 givenname: R. surname: Vlahos fullname: Vlahos, R. email: Stavros.selemidis@monash.edu, Stavros.selemidis@monash.edu organization: Department of Pharmacology & Therapeutics, Respiratory Research Group, Lung Health Research Centre, The University of Melbourne – sequence: 5 givenname: S. surname: Selemidis fullname: Selemidis, S. email: Stavros.selemidis@monash.edu, Stavros.selemidis@monash.edu organization: Department of Pharmacology, Monash University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24869957$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kE9vFSEUxYmpsf_8BsawdDNPYKAMG03T2NrkxZe0NXFHGLjjo5mBEWZq208v42tN3HQDJPeccw-_Q7QXYgCE3lGyqilRHymRVMgTtmKE8pViUkj1Ch1QwlTFuCR7y1vSatHso8OcbwmhNRfyDdpnvDlRSsgDBJeh62cIjwaf4juf5oxNcPhmfSWxsZO_M5OPAY9xgjB5MwH-tvnBcLz3zmSoHIwQXBnhq801HlN0s_1r8AEPxqY4bs1PyMfodWf6DG-f7iP0_fzLzdnXar25uDw7XVeWN3yq6q5uRddaKmwjOWVdK2vuhGKEq65pDTgpCG_Lh4Qj5bAKiJDcKkINcQ3UR-jDLrc0-TVDnvTgs4W-NwHinDUVnNeMF0RFynfSUjLnBJ0ekx9MetCU6AWwfgasF8B6B7jY3j9tmNsB3D_TM9Ei-LwT-NDFNJjfMfVOT-ahj6lLJlifl_gXV3z6L2ELpp-21iTQt3FOoQB8ueMf0OCfAg |
CitedBy_id | crossref_primary_10_1007_s00216_020_02466_2 crossref_primary_10_1186_s11658_020_00211_2 crossref_primary_10_1124_mol_114_095216 crossref_primary_10_1016_j_intimp_2023_110943 crossref_primary_10_1038_s41598_019_38864_5 crossref_primary_10_1016_j_biopha_2024_116722 crossref_primary_10_1134_S0006297920120068 crossref_primary_10_1586_14787210_2015_1094375 crossref_primary_10_1016_j_mehy_2020_109910 crossref_primary_10_1038_s41467_017_00057_x crossref_primary_10_1038_s41419_022_04775_z crossref_primary_10_1002_jmv_25872 crossref_primary_10_1016_S1875_5364_19_30079_2 crossref_primary_10_1016_j_jep_2023_117290 crossref_primary_10_3390_medicina58060810 crossref_primary_10_1128_CMR_00094_21 crossref_primary_10_1007_s42770_021_00663_4 crossref_primary_10_3389_fimmu_2017_01177 crossref_primary_10_3390_ijms21114084 crossref_primary_10_1093_carcin_bgv126 crossref_primary_10_3390_antiox12020483 crossref_primary_10_1016_j_freeradbiomed_2017_08_027 crossref_primary_10_1186_s12864_017_3803_6 crossref_primary_10_1155_2020_6401341 crossref_primary_10_1080_10408398_2021_1972407 crossref_primary_10_1016_j_biopha_2020_110345 crossref_primary_10_1042_CS20140321 crossref_primary_10_3389_fmicb_2022_1111930 crossref_primary_10_1016_j_freeradbiomed_2018_06_011 crossref_primary_10_1016_j_phymed_2019_153150 crossref_primary_10_1155_2016_8910396 crossref_primary_10_3390_pathogens12070928 crossref_primary_10_1016_j_virol_2016_06_003 crossref_primary_10_1016_j_biopha_2022_114000 crossref_primary_10_1016_j_antiviral_2017_04_010 crossref_primary_10_1155_2022_5589089 crossref_primary_10_3390_clinpract12040063 crossref_primary_10_1002_rmv_2240 crossref_primary_10_1007_s13258_020_01021_8 crossref_primary_10_1186_s12985_015_0284_6 crossref_primary_10_1371_journal_ppat_1004566 crossref_primary_10_3390_v8100269 crossref_primary_10_3389_fcimb_2021_804976 crossref_primary_10_1016_j_bbagen_2018_03_004 crossref_primary_10_3389_fphar_2024_1309682 crossref_primary_10_1016_j_cytogfr_2020_08_002 crossref_primary_10_1042_CS20210050 crossref_primary_10_1051_medsci_20183406028 crossref_primary_10_3892_mmr_2018_9089 crossref_primary_10_56294_saludcyt2023239 crossref_primary_10_1099_jgv_0_001961 crossref_primary_10_31857_S0320972520120064 crossref_primary_10_3390_antiox11081488 crossref_primary_10_1016_j_jdermsci_2015_12_011 crossref_primary_10_1186_s12985_020_01463_2 crossref_primary_10_1016_j_pupt_2015_06_006 crossref_primary_10_3390_v10080392 crossref_primary_10_1152_ajplung_00231_2016 crossref_primary_10_3390_nu12030616 crossref_primary_10_1111_imm_12530 |
Cites_doi | 10.4049/jimmunol.1201007 10.1126/science.1093616 10.1016/j.cell.2008.02.043 10.1165/rcmb.2011-0345OC 10.1371/journal.ppat.1001329 10.4049/jimmunol.164.11.5998 10.1073/pnas.93.6.2448 10.1016/j.freeradbiomed.2013.10.014 10.1038/nsmb769 10.1371/journal.pone.0048326 10.1038/sj.icb.7100026 10.1038/nrd3403 10.1128/JVI.76.20.10455-10464.2002 10.4049/jimmunol.1202574 10.1172/JCI27544 10.1007/s00281-008-0118-3 10.1002/eji.200635977 10.1016/S0092-8674(03)00314-3 10.4049/jimmunol.171.8.4392 10.1038/nri1630 10.1172/JCI114496 10.1189/jlb.0804442 10.1016/j.tips.2011.09.001 10.4049/jimmunol.178.6.3368 10.1016/j.pharmthera.2008.08.005 10.1371/journal.ppat.1001271 10.1016/j.virusres.2013.09.011 10.1007/s11427-009-0061-0 10.1152/physrev.00044.2005 10.1146/annurev-immunol-030409-101335 |
ContentType | Journal Article |
Copyright | 2014 Informa UK, Ltd. 2014 |
Copyright_xml | – notice: 2014 Informa UK, Ltd. 2014 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.3109/10715762.2014.927579 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry |
EISSN | 1029-2470 |
EndPage | 947 |
ExternalDocumentID | 10_3109_10715762_2014_927579 24869957 927579 |
Genre | Original Articles Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .HR 00X 03L 0BK 0R~ 29H 30N 36B 4.4 53G 5GY 5VS A8Z AAAVI AAGME AAJMT AALDU AALIY AAMIU AAOAP AAPUL AAPXX AAQRR ABBKH ABCCY ABDBF ABFIM ABJVF ABJYH ABLIJ ABLKL ABPTK ABQHQ ABXUL ACBBU ACDHJ ACFUF ACGEJ ACGFS ACQMU ACTIO ADCVX ADFCX ADGTB ADGTR ADOPC ADRBQ ADXPE AEGYZ AEISY AENEX AEOZL AEPSL AEYOC AEYQI AFDYB AFFNX AFKVX AFOSN AFWLO AGDLA AHDLD AIJEM AIRXU AJWEG AKBVH AKOOK ALIIL ALMA_UNASSIGNED_HOLDINGS ALQZU APNXG AQRUH AURDB AWQZV AWYRJ BABNJ BFWEY BLEHA CAG CCCUG COF CS3 CWRZV DGEBU DKSSO DU5 EAP EBC EBD EBS EJD EMB EMK EMOBN EPL EST ESX F5P H13 HGUVV HZ~ J.N JEPSP KRBQP KSSTO KWAYT KYCEM LJTGL M44 M4Z MM. O9- OWHGL P2P PCLFJ RNANH RNS ROSJB RTWRZ SV3 TFDNU TFL TFT TFW TQWBC TTHFI TUS V1S Z0Y ZGOLN ZXP ~1N ABFMO ABJNI ABPAQ ABTAA ABXYU AHDZW CGR CUY CVF ECM EIF ESTFP NPM NUSFT TBQAZ TDBHL TUROJ AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c484t-3f3b5fbc15c87412fb734d592049f8baed7504b7625d0625c9e0574c901a0d8e3 |
ISSN | 1071-5762 |
IngestDate | Sat Oct 26 00:40:38 EDT 2024 Fri Aug 23 03:08:42 EDT 2024 Tue Oct 15 23:51:55 EDT 2024 Tue Jun 13 19:29:44 EDT 2023 Wed Jun 21 01:44:23 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | superoxide poly I:C oxidative stress imiquimod lung pathology |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c484t-3f3b5fbc15c87412fb734d592049f8baed7504b7625d0625c9e0574c901a0d8e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 24869957 |
PQID | 1544324029 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1544324029 crossref_primary_10_3109_10715762_2014_927579 informaworld_taylorfrancis_310_3109_10715762_2014_927579 pubmed_primary_24869957 informahealthcare_journals_10_3109_10715762_2014_927579 |
PublicationCentury | 2000 |
PublicationDate | 2014-08-01 |
PublicationDateYYYYMMDD | 2014-08-01 |
PublicationDate_xml | – month: 08 year: 2014 text: 2014-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Free radical research |
PublicationTitleAlternate | Free Radic Res |
PublicationYear | 2014 |
Publisher | Informa Healthcare Taylor & Francis |
Publisher_xml | – name: Informa Healthcare – name: Taylor & Francis |
References | CIT0010 CIT0011 Vlahos R (CIT0002) 2012; 33 Snelgrove RJ (CIT0014) 2006; 36 Groemping Y (CIT0013) 2003; 113 Yatmaz S (CIT0008) 2013; 48 Dang PMC (CIT0020) 2006; 116 CIT0016 CIT0015 CIT0018 CIT0017 Le Goffic R (CIT0029) 2007; 178 Kash JC (CIT0005) 2014; 67 CIT0021 Akaike T (CIT0003) 1996; 93 Lee YH (CIT0006) 2013; 178 CIT0023 El-Benna J (CIT0025) 2008; 30 La Gruta NL (CIT0001) 2007; 85 Harrison CB (CIT0012) 2012; 7 Wang H (CIT0022) 2009; 52 CIT0024 Makni-Maalej K (CIT0030) 2012; 189 Vlahos R (CIT0007) 2011; 7 CIT0004 CIT0026 Sheppard FR (CIT0027) 2005; 78 Yang CS (CIT0019) 2013; 190 CIT0028 CIT0009 |
References_xml | – volume: 189 start-page: 4657 year: 2012 ident: CIT0030 publication-title: J Immunol doi: 10.4049/jimmunol.1201007 contributor: fullname: Makni-Maalej K – ident: CIT0017 doi: 10.1126/science.1093616 – ident: CIT0004 doi: 10.1016/j.cell.2008.02.043 – volume: 48 start-page: 17 year: 2013 ident: CIT0008 publication-title: Am J Respir Cell Mol Biol doi: 10.1165/rcmb.2011-0345OC contributor: fullname: Yatmaz S – ident: CIT0021 doi: 10.1371/journal.ppat.1001329 – ident: CIT0018 doi: 10.4049/jimmunol.164.11.5998 – volume: 93 start-page: 2448 year: 1996 ident: CIT0003 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.93.6.2448 contributor: fullname: Akaike T – volume: 67 start-page: 235 year: 2014 ident: CIT0005 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2013.10.014 contributor: fullname: Kash JC – ident: CIT0023 doi: 10.1038/nsmb769 – volume: 7 start-page: e48326 year: 2012 ident: CIT0012 publication-title: PLoS One doi: 10.1371/journal.pone.0048326 contributor: fullname: Harrison CB – volume: 85 start-page: 85 year: 2007 ident: CIT0001 publication-title: Immunol Cell Biol doi: 10.1038/sj.icb.7100026 contributor: fullname: La Gruta NL – ident: CIT0010 doi: 10.1038/nrd3403 – ident: CIT0024 doi: 10.1128/JVI.76.20.10455-10464.2002 – volume: 190 start-page: 6368 year: 2013 ident: CIT0019 publication-title: J Immunol doi: 10.4049/jimmunol.1202574 contributor: fullname: Yang CS – volume: 116 start-page: 2033 year: 2006 ident: CIT0020 publication-title: J Clin Invest doi: 10.1172/JCI27544 contributor: fullname: Dang PMC – volume: 30 start-page: 279 year: 2008 ident: CIT0025 publication-title: Semin Immunopathol doi: 10.1007/s00281-008-0118-3 contributor: fullname: El-Benna J – volume: 36 start-page: 1364 year: 2006 ident: CIT0014 publication-title: Eur J Immunol doi: 10.1002/eji.200635977 contributor: fullname: Snelgrove RJ – volume: 113 start-page: 343 year: 2003 ident: CIT0013 publication-title: Cell doi: 10.1016/S0092-8674(03)00314-3 contributor: fullname: Groemping Y – ident: CIT0028 doi: 10.4049/jimmunol.171.8.4392 – ident: CIT0016 doi: 10.1038/nri1630 – ident: CIT0026 doi: 10.1172/JCI114496 – volume: 78 start-page: 1025 year: 2005 ident: CIT0027 publication-title: J Leukoc Biol doi: 10.1189/jlb.0804442 contributor: fullname: Sheppard FR – volume: 33 start-page: 3 year: 2012 ident: CIT0002 publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2011.09.001 contributor: fullname: Vlahos R – volume: 178 start-page: 3368 year: 2007 ident: CIT0029 publication-title: J Immunol doi: 10.4049/jimmunol.178.6.3368 contributor: fullname: Le Goffic R – ident: CIT0011 doi: 10.1016/j.pharmthera.2008.08.005 – volume: 7 start-page: 1001271 year: 2011 ident: CIT0007 publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1001271 contributor: fullname: Vlahos R – volume: 178 start-page: 411 year: 2013 ident: CIT0006 publication-title: Virus Res doi: 10.1016/j.virusres.2013.09.011 contributor: fullname: Lee YH – volume: 52 start-page: 464 year: 2009 ident: CIT0022 publication-title: Sci China C Life Sci doi: 10.1007/s11427-009-0061-0 contributor: fullname: Wang H – ident: CIT0009 doi: 10.1152/physrev.00044.2005 – ident: CIT0015 doi: 10.1146/annurev-immunol-030409-101335 |
SSID | ssj0013457 |
Score | 2.3855548 |
Snippet | Abstract
Influenza A virus infects resident alveolar macrophages in the respiratory tract resulting in Toll like receptor 7 (TLR7) activation that triggers an... Influenza A virus infects resident alveolar macrophages in the respiratory tract resulting in Toll like receptor 7 (TLR7) activation that triggers an... |
SourceID | proquest crossref pubmed informaworld informahealthcare |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 940 |
SubjectTerms | Animals Humans imiquimod Influenza A virus - genetics Influenza A virus - metabolism lung pathology Macrophages - metabolism Male Membrane Glycoproteins - metabolism Mice Mice, Inbred C57BL NADPH Oxidase 2 NADPH Oxidases - metabolism Oxidative Stress Phosphorylation poly I:C Reactive Oxygen Species - metabolism Signal Transduction superoxide Toll-Like Receptor 7 - genetics Toll-Like Receptor 7 - metabolism |
Title | Influenza A virus and TLR7 activation potentiate NOX2 oxidase-dependent ROS production in macrophages |
URI | https://www.tandfonline.com/doi/abs/10.3109/10715762.2014.927579 https://www.ncbi.nlm.nih.gov/pubmed/24869957 https://search.proquest.com/docview/1544324029 |
Volume | 48 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgk4AXNMZt3GQk3qKMxrET-7Ebm8plm1Q6MfESOY6jVmJN1aUI7ddzfMmFbuP2ElVJEyv5vpycc3z8HYTecCZFrAgNhZAQoLAkDzmNeDhgmmhOCqZtvuPoOBmd0g9nrDfRbleX1Pmuurx2Xcn_oAr7AFezSvYfkG0vCjvgN-ALW0AYtn-F8XvXYeRSwuv9fbZcOb3lyadxajUyXLY1WFS1KQkCpzI4PjkjQfVjVsC3K2z639bB-OSzKdQqnJKsSYGcS9PaawrG5qLvvh4utQ6W0s3teJ2gNp88sVnXg25tw55tAeTr8_eCcZdmHcHARo_fkuhjr-3XNzmtenWMPh0R0bYYDr4mzoSaghpCXTuQxsZS3uMS7xlM4cSa1g157HRQITaNICAyC-YiuitIylznmR62i3MLLqE8EcJpXa8JaDeHbqNNAtYIzODmcPTu65dusomy1K2qNMO-vW5QoxntL_OLA7Pl5W2nbbHemuTtzYGLdWAmW-i-jzzw0NHoAbql59vo7n7T8G8b3TnydRYPkW6ZhYfYMgsDs7BhFu6YhTtmYcMsfIVZGJiFO2bh2Rz3mPUInR4eTPZHoW_IESrKaR3GZZyzMlcRUxw8UVLmaUwLJgiEmSXPpS5Ms4Acnh0rBrBRQkM4QBX4nHJQcB0_Rhvzaq6fIixKUiSSQ3CiSqoZl1rxksLnJVEAUVHuoLB5ytnC6a5kEK8agLIGoMwAlDmAdlB6BYrMv6oXfziT9wHLapspK11bG3Pa70593YCbAVZmqk3OdbWCAY2spJm4hP88cai3t9EQ6dmNR56je92r9QJt1MuVfgm-b52_8tz9CZJGpss |
link.rule.ids | 315,783,787,27936,27937,60214,61003,61689,61870 |
linkProvider | Library Specific Holdings |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwELZgSGwvMAYbG7-MxKtL4tiJ_ThNmzpoO2l00t4sx7G1CpFWa4rQ_vrdxclgQwMJXpKH5OKcfba_s8_fEfJBSaszxwXT2oKDIvOSKZEqlkjPveKV9O16x3iSD8_Ep3PZRxMuu7BK9KFDJIpox2rs3LgY_bF1MRMN9yIFnIznqFIx0LyQhX5IHuUpGB-e4kgmPzcSREv2iRIMReLpuXu_cmt22uy4Sy9uIrHu8Jnej0rb2enoKSl7vWJQytfBqikH7uoO5eN_Kb5JnnTYle5HY3tGHvh6i6wf9CnjtsjjcbdT_5z445j95MrSffp9drlaUiiWTkenBcWzFHElmC7mDYYrAeClk5NzTuc_ZhXMq6zPzdvQ05MvdBFpaVFgVtNvFtOOXcBAuHxBzo4OpwdD1qV0YE4o0bAsZKUMpUulU4BleCiLTFRSc3BUgiqtr5BuvgQVZZXAxWkPgFI4QC02qZTPtslaPa_9S0J14FVuFcBbF4SXynqngoABKnc6y6uwS1jflGYRmTsMeDxYj6avR4P1aGI97pLit_Y2XYde_kVS_WoVpmnXWkJMjIJifxJ931uQgbbCzRpb-_kKCkRiQtz6gnd2omndqMGFyrWWxd4___I7sj6cjkdmdDz5_Ips4JMY1fiarDWXK_8GkFZTvm370jWbxxin |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagSIULlPIqTyNx9ZI4dmIfq8KqhXaLSivtzXL8UFeI7KqbRai_npk4KaWoIMElOSQTx_bY_sae-YaQN0paXTgumNYWDBRZ1kyJXLFMBh4U9zJ0-x0Hk3L3RHyYyumlKH50q0QbOiaiiG6uxsG98PFtZ2FmGu5VDjAZw6hyMdK8kpW-SW6VealQr4ts8vMcQXRcnyjBUCQFz137lV8Wp42euvT0whHrCp3p9aC0W5zG94gdqpV8Ur6MVm09cudXGB__p94b5G6PXOl2UrX75EZoNsntnSFh3CZZP-jP6R-QsJdyn5xbuk2_zc5WSwql0uP9o4piJEXaB6aLeYvOSgB36eRwyun8-8zDqsqGzLwtPTr8TBeJlBYFZg39ajHp2ClMg8uH5GT8_nhnl_UJHZgTSrSsiEUtY-1y6RQgGR7rqhBeag5mSlS1DR7J5muoovQZXJwOACeFA8xiM69C8YisNfMmPCFUR-5LqwDcuiiCVDY4FQVMT6XTRenjFmFDT5pF4u0wYO9gO5qhHQ22o0ntuEWq37rb9MN5-RdJdVkpTNvttMSUFgXF_iT6elAgA32FRzW2CfMVFIi0hHjwBe88Tpp1UQ0uVKm1rJ7-8y-_Iuuf3o3N_t7k4zNyBx8kl8bnZK09W4UXALPa-mU3kn4AS7gXXw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influenza+A+virus+and+TLR7+activation+potentiate+NOX2+oxidase-dependent+ROS+production+in+macrophages&rft.jtitle=Free+radical+research&rft.au=To%2C+E+E&rft.au=Broughton%2C+B+R+S&rft.au=Hendricks%2C+K+S&rft.au=Vlahos%2C+R&rft.date=2014-08-01&rft.eissn=1029-2470&rft.volume=48&rft.issue=8&rft.spage=940&rft_id=info:doi/10.3109%2F10715762.2014.927579&rft_id=info%3Apmid%2F24869957&rft.externalDocID=24869957 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1071-5762&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1071-5762&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1071-5762&client=summon |